These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20110384)

  • 21. NDM-1-Producing Citrobacter freundii, Escherichia coli, and Acinetobacter baumannii Identified from a Single Patient in China.
    Huang YM; Zhong LL; Zhang XF; Hu HT; Li YQ; Yang XR; Feng LQ; Huang X; Tian GB
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5073-7. PubMed ID: 26055374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of qnrVC6, within a new genetic context, in an NDM-1-producing Citrobacter freundii clinical isolate from Uruguay.
    Bado I; Papa-Ezdra R; Cordeiro N; Outeda M; Caiata L; García-Fulgueiras V; Seija V; Vignoli R
    J Glob Antimicrob Resist; 2018 Sep; 14():95-98. PubMed ID: 29526748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of a multidrug-resistant Citrobacter freundii ST8 harboring an unusual VIM-4 gene cassette in Poland.
    Majewski P; Wieczorek P; Łapuć I; Ojdana D; Sieńko A; Sacha P; Kłoczko J; Tryniszewska E
    Int J Infect Dis; 2017 Aug; 61():70-73. PubMed ID: 28602727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
    Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
    J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 16S rDNA sequencing revealed Citrobacter freundii as the cause of liver abcess after banding of rectal haemorrhoids.
    Wiese L; Nielsen X; Andresen K; Kjaer A; David K
    J Infect; 2005 Feb; 50(2):163-4. PubMed ID: 15667920
    [No Abstract]   [Full Text] [Related]  

  • 26. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes.
    Liu LH; Wang NY; Wu AY; Lin CC; Lee CM; Liu CP
    J Microbiol Immunol Infect; 2018 Aug; 51(4):565-572. PubMed ID: 28711438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Spondylodiscitis and epidural abscess due to Citrobacter freundii].
    Hernández MA; Hernández JL; Cabello M; Calvo J
    Enferm Infecc Microbiol Clin; 2002 Jan; 20(1):46-7. PubMed ID: 11820988
    [No Abstract]   [Full Text] [Related]  

  • 28. Cefotaxime-resistant Citrobacter freundii in isolates from blood in a tertiary teaching hospital in Northern Taiwan.
    Liu CP; Weng LC; Tseng HK; Wang NY; Lee CM
    J Infect; 2007 Oct; 55(4):363-8. PubMed ID: 17572502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.
    Wen S; Feng D; Lu Z; Liu J; Peters BM; Tang H; Su D; Lin YP; Yang L; Xu Z; Shirtliff ME; Chen D
    Microb Pathog; 2018 Apr; 117():356-360. PubMed ID: 29452198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India.
    Poirel L; Ros A; Carricajo A; Berthelot P; Pozzetto B; Bernabeu S; Nordmann P
    Antimicrob Agents Chemother; 2011 Jan; 55(1):447-8. PubMed ID: 20974865
    [No Abstract]   [Full Text] [Related]  

  • 31. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
    Ahmed AM; Shimamoto T
    Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression.
    Zhang R; Yang L; Cai JC; Zhou HW; Chen GX
    J Med Microbiol; 2008 Mar; 57(Pt 3):332-337. PubMed ID: 18287296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae.
    Chew KL; Tay MKL; Cheng B; Lin RTP; Octavia S; Teo JWP
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760136
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence and characteristics of aac(6')-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea.
    Kim SY; Park YJ; Yu JK; Kim YS; Han K
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):314-8. PubMed ID: 19216942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Companion animals: a relevant source of extended-spectrum β-lactamase-producing fluoroquinolone-resistant Citrobacter freundii.
    Ewers C; Bethe A; Wieler LH; Guenther S; Stamm I; Kopp PA; Grobbel M
    Int J Antimicrob Agents; 2011 Jan; 37(1):86-7. PubMed ID: 21074371
    [No Abstract]   [Full Text] [Related]  

  • 37. Low rates of antimicrobial-resistant Enterobacteriaceae in wildlife in Taï National Park, Côte d'Ivoire, surrounded by villages with high prevalence of multiresistant ESBL-producing Escherichia coli in people and domestic animals.
    Albrechtova K; Papousek I; De Nys H; Pauly M; Anoh E; Mossoun A; Dolejska M; Masarikova M; Metzger S; Couacy-Hymann E; Akoua-Koffi C; Wittig RM; Klimes J; Cizek A; Leendertz FH; Literak I
    PLoS One; 2014; 9(12):e113548. PubMed ID: 25474243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of CFE-2, a new plasmid-encoded AmpC β-lactamase from a clinical isolate of Citrobacter freundii.
    Chen CM; Huang M; Wu HJ; Guo MK; Wu LT
    Int J Antimicrob Agents; 2018 Sep; 52(3):421-424. PubMed ID: 29944954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial characterisation of the acrAB locus in two Citrobacter freundii clinical isolates.
    Sánchez-Céspedes J; Vila J
    Int J Antimicrob Agents; 2007 Sep; 30(3):259-63. PubMed ID: 17631985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.